Key result
Apparent resistant hypertension was present in 18.9% of Ghanaian patients with hypertension, and was independently associated with longer hypertension duration and eGFR < 60 mL/min (OR 1.73).
Why the study?
Apparent resistant hypertension carries significant morbidity and mortality, but data on its burden from sub-Saharan Africa are scarce.
Cross-Sectional (n=2,912)
Yes
Answers are grounded in this paper and cite their sources.
Apparent resistant hypertension is highly prevalent (18.9%) among Ghanaians with hypertension and is associated with longer hypertension duration and reduced eGFR.
Apparent resistant hypertension (ARH) is rife among people living with hypertension and is associated with significant morbidity and mortality. There is however paucity of data from sub-Saharan Africa on the burden of ARH. We sought to report on the frequency and factors associated with ARH among a cohort of Ghanaians with hypertension. A cross-sectional study involving 2912 participants with hypertension enrolled at five health facilities in Ghana. ARH was defined as either office BP ≥ 140/90 mm Hg on 3 or more antihypertensive medications or on 4 or more antihypertensive medications regardless of BP. Factors associated with ARH were evaluated in a multivariate logistic regression model. We found 550 out of 2,912 (18.9%) of study participants had ARH. Out of these 550 subjects, 511 (92.9%) were on 3 or more antihypertensive medications with BP ≥ 140/90 mm Hg and 39 (7.1%) were on 4 or more antihypertensive medications with BP ≥ 140/90 mm Hg. The prevalence of ARH was 15.5% among elderly aged 75 + years (n = 341), 20.7% among 65-74 years (n = 588), and 18.9% among those ≤ 64 years (n = 1983). The adjusted odds ratio (95% CI) of factors independently associated with ARH was duration of hypertension, 1.05 (1.03-1.06) for each year rise; eGFR < 60 mL/min, 1.73 (1.33-2.25); and diabetes mellitus, 0.59 (0.46-0.76). Attaining secondary level education and residence in a peri-urban setting were significantly associated with ARH though not in a dose-dependent manner. ARH is rife among Ghanaians and may negatively impact on cardiovascular outcomes in the long term.
No takes yet. Share an insight, caveat, or question.
Ayisi‐Boateng et al. (2020) conducted a cross-sectional in Hypertension (n=2,912). Clinical and demographic factors (e.g., hypertension duration, eGFR, diabetes) was evaluated on Apparent resistant hypertension (ARH). Apparent resistant hypertension was present in 18.9% of Ghanaian patients with hypertension, and was independently associated with longer hypertension duration and eGFR < 60 mL/min (OR 1.73).
Synapse has enriched 10 related papers. Consider them for comparative context: